ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
0,00%
Bitcoin
63.992,72
0,92%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PAVmed Inc (PAVMZ)

  7. PAVmed Inc (PAVMZ) News

PAVMZ

PAVmed (PAVMZ)

PAVmed Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PAVMZ
DatumZeitQuelleÜberschriftSymbolFirma
17/01/202322h05Business WirePAVmed and Lucid Diagnostics Provide Strategic Business UpdateNASDAQ:PAVMZPAVmed Inc
11/01/202314h00Business WirePAVmed and Lucid Diagnostics to Provide Strategic Business UpdateNASDAQ:PAVMZPAVmed Inc
22/12/202214h25Business WirePAVmed Partners with Novosound on Ultrasound Imaging TechnologyNASDAQ:PAVMZPAVmed Inc
15/12/202214h25Business WirePAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care PlatformNASDAQ:PAVMZPAVmed Inc
08/12/202214h25Business WireLucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic IndustryNASDAQ:PAVMZPAVmed Inc
01/12/202214h25Business WireLucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer ResearchNASDAQ:PAVMZPAVmed Inc
14/11/202222h40Business WireLucid Diagnostics Provides Business Update and Third Quarter 2022 Financial ResultsNASDAQ:PAVMZPAVmed Inc
11/11/202214h25Business WirePAVmed to Participate in BTIG Digital Health ForumNASDAQ:PAVMZPAVmed Inc
10/11/202214h25Business WireLucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:PAVMZPAVmed Inc
09/11/202214h25Business WireLucid Diagnostics Commences Production of EsoCheck Devices with High-Volume ManufacturerNASDAQ:PAVMZPAVmed Inc
03/11/202213h25Business WirePAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022NASDAQ:PAVMZPAVmed Inc
02/11/202213h25Business WireLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022NASDAQ:PAVMZPAVmed Inc
30/08/202214h25Business WirePAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech ConferenceNASDAQ:PAVMZPAVmed Inc
16/08/202222h40Business WirePAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial ResultsNASDAQ:PAVMZPAVmed Inc
11/08/202214h25Business WireLucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and OhioNASDAQ:PAVMZPAVmed Inc
04/08/202214h25Business WireNewly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® TechnologiesNASDAQ:PAVMZPAVmed Inc
19/07/202214h25Business WirePAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate AmericaNASDAQ:PAVMZPAVmed Inc
18/07/202214h25Business WireLucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 ConferenceNASDAQ:PAVMZPAVmed Inc
13/05/202214h25Business WirePAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEONASDAQ:PAVMZPAVmed Inc
28/04/202222h05GlobeNewswire Inc.PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action LawsuitNASDAQ:PAVMZPAVmed Inc
26/04/202214h25Business WirePAVmed to Hold a Business Update Conference Call on May 12, 2022NASDAQ:PAVMZPAVmed Inc
29/03/202222h11Business WirePAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:PAVMZPAVmed Inc
23/03/202213h25Business WirePAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test CentersNASDAQ:PAVMZPAVmed Inc
17/03/202213h25Business WirePAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion SystemNASDAQ:PAVMZPAVmed Inc
10/03/202214h25Business WirePAVmed Subsidiary Veris Health Launches World-Class Technology Advisory BoardNASDAQ:PAVMZPAVmed Inc
08/03/202214h30Business WirePAVmed to Hold a Business Update Conference Call on March 29, 2022NASDAQ:PAVMZPAVmed Inc
07/03/202214h30Business WireLucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022NASDAQ:PAVMZPAVmed Inc
04/03/202214h25Business WireLucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech SummitNASDAQ:PAVMZPAVmed Inc
03/03/202214h25Business WirePAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing GrowthNASDAQ:PAVMZPAVmed Inc
24/02/202214h25Business WirePAVmed Appoints Shaun O’Neil as Chief Operating OfficerNASDAQ:PAVMZPAVmed Inc
 Showing the most relevant articles for your search:NASDAQ:PAVMZ

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
NYSE
NKE
Nike
TG
NOV
Novo Nordisk
NASDAQ
TSLA
Tesla
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
TG
MBG
MercedesBenz
NYSE
KO
Coca Cola
TG
DTE
Deutsche Telekom
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
TG
BAS
BASF
CCOM
US500
US 500
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten